Why Need to Watch : Hewlett-Packard (NYSE:HPQ), Sonus Networks (NASDAQ:SONS), Rock Creek Pharmaceuticals (NASDAQ:RCPI), OncoMed Pharmaceuticals (NASDAQ:OMED), Lamar Advertising. (NASDAQ:LAMR)

Hewlett-Packard Company (NYSE:HPQ) has just expanded its HP Helion portfolio with the launch of a new, low-cost virtual private cloud offering. Called HP Helion Virtual Private Cloud (VPC) Lean, the new infrastructure-as-a-service product touts enhanced workload performance and better service delivery at a significantly reduced cost compared to HP’s other cloud services. Hewlett-Packard Company (NYSE:HPQ) belongs to Technology sector. Its net profit margin is 4.90% and weekly performance is -2.22%. On last trading day company shares ended up $34.82. Hewlett-Packard Company (NYSE:HPQ) distance from 50-day simple moving average (SMA50) is 1.46%.

Sonus Networks, Inc (NASDAQ:SONS) CFO Mark T. Greenquist bought 15,000 shares of Sonus Networks stock in a transaction dated Monday, August 4th. The shares were purchased at an average price of $3.59 per share, with a total value of $53,850.00. Following the acquisition, the chief financial officer now directly owns 280,000 shares of the company’s stock, valued at approximately $1,005,200. Sonus Networks, Inc. (NASDAQ:SONS) shares decreased -2.71% in last trading session and ended the day at $3.59. SONS Gross Margin is 63.50% and its return on assets is -3.00%. Sonus Networks, Inc. (NASDAQ:SONS) quarterly performance is 10.46%.

Drug maker Rock Creek Pharmaceuticals Inc (NASDAQ:RCPI) reported on 6th August that it had brought on board two new independent directors to its board, in the form of “Ms. Lee M. Canaan, CFA and Mr. Edward J. McDonnell, MPH” who were elected to take the vacant slots. On 07 August, Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) shares increased 20.25% and was closed at $0.48. RCPI EPS growth in last 5 year was 0.00%. Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) year to date (YTD) performance is -58.53%.

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) Thursday reported second-quarter 2014 net loss of $15.6 million or $0.53 per share, versus a $9.6 million or $8.83 per share of loss, in the same period last year. On average, 5 analysts polled by Thomson Reuters expected the company to report a loss of $0.03 per share for the quarter. OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) ended the last trading day at $20.92. Company weekly volatility is calculated as 5.33%and price to cash ratio as 2.18. OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) showed a weekly performance of -3.15%.

Baton Rouge-based Lamar Advertising Co. (NASDAQ:LAMR) reported net income dropped to $15.4 million, or 16 cents per share, compared to $23.1 million, or 24 cents per share, compared to the second quarter of 2013. Lamar Advertising Co. (NASDAQ:LAMR) shares decreased -0.74% in last trading session and ended the day on $49.70. LAMR Gross Margin is 64.60% and its return on assets is 1.20%. Lamar Advertising Co. (NASDAQ:LAMR) quarterly performance is 2.56%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone